Follow
Guillem Pons Barcons
Guillem Pons Barcons
PhD Student, Vall d'Hebrón Institut of Research (VHIR)
Verified email at vhir.org
Title
Cited by
Cited by
Year
miRNA-7 and miRNA-324-5p regulate alpha9-Integrin expression and exert anti-oncogenic effects in rhabdomyosarcoma
C Molist, N Navarro, I Giralt, P Zarzosa, G Gallo-Oller, G Pons, ...
Cancer Letters 477, 49-59, 2020
252020
Dickkopf proteins and their role in cancer: A family of Wnt antagonists with a dual role
I Giralt, G Gallo-Oller, N Navarro, P Zarzosa, G Pons, A Magdaleno, ...
Pharmaceuticals 14 (8), 810, 2021
132021
Dickkopf-1 inhibition reactivates Wnt/β-catenin signaling in rhabdomyosarcoma, induces myogenic markers in vitro and impairs tumor cell survival in vivo
I Giralt, G Gallo-Oller, N Navarro, P Zarzosa, G Pons, A Magdaleno, ...
International Journal of Molecular Sciences 22 (23), 12921, 2021
52021
A mechanism-based sphingosine-1-phosphate lyase inhibitor
G Pons, D Riba, M Casasampere, E Izquierdo, JL Abad, G Fabriàs, ...
The Journal of Organic Chemistry 85 (2), 419-429, 2019
52019
Targeting the hedgehog pathway in rhabdomyosarcoma
P Zarzosa, L Garcia-Gilabert, R Hladun, G Guillén, G Gallo-Oller, G Pons, ...
Cancers 15 (3), 727, 2023
42023
Integrin alpha9 emerges as a key therapeutic target to reduce metastasis in rhabdomyosarcoma and neuroblastoma
N Navarro, C Molist, J Sansa-Girona, P Zarzosa, G Gallo-Oller, G Pons, ...
Cellular and Molecular Life Sciences 79 (11), 546, 2022
32022
Analysis of cancer genomic amplifications identifies druggable collateral dependencies within the amplicon
G Pons, G Gallo-Oller, N Navarro, P Zarzosa, J Sansa-Girona, ...
Cancers 15 (6), 1636, 2023
12023
Combined inhibition of MDM2 and PARP lead to a synergistic anti-tumoral response in p53 wild-type rhabdomyosarcoma
G Pons, G Gallo-Oller, L García-Gilabert, P Zarzosa, J Sansa-Girona, ...
Cancer Research 84 (6_Supplement), 5473-5473, 2024
2024
TRIB3 silencing promotes the downregulation of Akt pathway and PAX3-FOXO1 in high-risk rhabdomyosarcoma
GO Gallo-Oller, G Pons, J Sansa-Girona, N Navarro, P Zarzosa, ...
bioRxiv, 2023.12. 01.569530, 2023
2023
THE ONCOGENIC ROLE OF HEDGEHOG PATHWAY CO-RECEPTORS IN RHABDOMYOSARCOMA: EXPANDING KNOWLEDGE TO DISCOVER NEW THERAPEUTIC TARGETS
J Roma, P Zarzosa, S Gallego Melcon, J Sanchez De Toledo, L Moreno, ...
PEDIATRIC BLOOD & CANCER 69, S258-S259, 2022
2022
A novel and potent strategy for blocking the Hedgehog pathway to treat rhabdomyosarcoma
P Zarzosa, N Navarro, J Sansa-Girona, G Pons, G Gallo-Oller, ...
European Journal of Cancer 174, S28, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–11